AdvanCell, Inc. — Form D

AdvanCell, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2026-07-16. The offering totals $315.0M, of which $218.3M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2026-07-16
• Form: D
• Accession: 0000950172-26-000185
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $315.0M
• Amount sold: $218.3M
• Remaining: $96.7M
• Investors: 41
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-591090

Issuer

• Name: AdvanCell, Inc.
• CIK: 0002144758
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 245 MAIN STREET, CAMBRIDGE, MA, 02142
• Phone: +64 22 799 1300

Officers, directors & promoters (11)

More

• CIK 2144758 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search